Availability of Medication for Opioid Use Disorder Among Accountable Care Organizations: Evidence From a National Survey.

ABSTRACT:

Objective

This report aimed to assess how accountable care organizations (ACOs) addressed ongoing opioid use disorder treatment needs over time.

Methods

Responses from the 2018 (N=308 organizations) and 2022 (N=276) National Survey of Accountable Care Organizations (response rate=55% in both years) were used to examine changes in availability of medication for opioid use disorder (MOUD) among ACOs with Medicare and Medicaid contracts.

Results

The percentage of respondents offering at least one MOUD grew from 39% in 2018 to 52% in 2022 (p<0.01). MOUDs were more likely to be available in 2022 among ACOs with (vs. without) in-network substance use treatment facilities (80% vs. 33%, p<0.001). The percentage of 2022 respondents who reported offering MOUD was similar in sta

SUBMITTER: Newton H 

PROVIDER: S-EPMC10895446 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature